Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry^[1]^[2].

References:

[1]. Ma HC, et al. Homochiral Covalent Organic Framework for Catalytic Asymmetric Synthesis of a Drug Intermediate. J Am Chem Soc. 2020 Jul 22;142(29):12574-12578. [Content Brief]

[2]. Ramachary D B, et al. Development of pharmaceutical drugs, drug intermediates and ingredients by using direct organo‐click reactions[J]. 2008.

Drug Intermediate Related Products (686):

By Effects:	Controls (35) Inhibitor (1)

Cat. No.	Product Name	Effect	Purity	Chemical Structure

HY-W006202

BOC-(1S,3R)-3-aminocyclopentanecarboxylic acid
BOC-(1S,3R)-3-aminocyclopentanecarboxylic acid ((1S,3R)-3-[(tert-Butoxycarbonyl)amino]cyclopentanecarboxylic acid) is a synthetic intermediate useful for pharmaceutical synthesis.

HY-133716

Pantoprazole N-oxide
Pantoprazole N-oxide (Impurity-VI) is the impurity found during the Pantoprazole (HY-17507) production. Pantoprazole is an inhibitor for proton pump (PPI) that can be used for diseases related to excessive gastric acid, such as gastric ulcers and gastroesophageal reflux disease (GERD).

HY-135888

TP748		99.14%
TP748,an isoxazole, is a key intermediate for fully synthetic tetracyclines.

HY-N7033R

UDP-glucuronic acid (trisodium) (Standard)
UDP-glucuronic acid (trisodium) (Standard) is the analytical standard of UDP-glucuronic acid (trisodium). This product is intended for research and analytical applications. UDP-?glucuronic acid trisodium (Uridine-5'-diphosphoglucuronic acid trisodium salt) is a critical precursor for essential glycoconjugates across biological kingdoms, ranging from mammalian glycosaminoglycans and plant cell wall polysaccharides to bacterial capsule glycoglycerolipids.

HY-W128579

2-Pyrimidinepropanoic acid	Control
2-Pyrimidinepropanoic acid is a synthetic intermediate useful for pharmaceutical synthesis.

HY-U00410

PDE4 inhibitor intermediate 1
PDE4 inhibitor intermediate 1 is an intermediate for PDE4 inhibitor synthesis.

Name
Email *

	Sorry, but the email address you supplied was invalid.